Medicinsk Oxygen Strandmollen (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the bloodstream, raising arterial oxygen pressure. This increased oxygen availability enhances the gradient for delivery to tissues, supporting aerobic metabolism, ATP production, and the function of vital organs that depend on adequate oxygen supply.

The prescribed dose of Medicinsk Oxygen Strandmollen is determined by the treating clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. Dosage is expressed as flow rate (e.g., liters per minute) and duration, and must be individualized for each patient.

Safety data for oxygen therapy in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Clinicians should weigh potential benefits against any theoretical risks and use the lowest effective concentration under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Medicinsk Oxygen Strandmollen is a high‑purity medical gas supplied in cylinder form, offering precise flow control and portability. Compared with liquid oxygen systems or concentrators, cylinders provide immediate, on‑demand oxygen without the need for power sources, making them suitable for emergency and transport settings.

Store the oxygen cylinder at ambient temperature in a well‑ventilated, dry area, protected from direct sunlight and heat. Keep the cylinder upright, secure it to prevent tipping, and ensure valves are closed when not in use. Follow all local regulations for compressed gas storage.

The product is administered by inhalation using a compatible delivery system such as a nasal cannula, face mask, or mechanical ventilator circuit. The prescriber sets the appropriate flow rate and duration, and healthcare personnel monitor the patient’s oxygen saturation throughout therapy.

Serious risks include oxygen toxicity, which can damage lung tissue or the central nervous system, and fire hazards, as oxygen supports combustion. Patients should be monitored for signs of hyperoxia, and strict no‑smoking policies must be enforced in areas where the gas is used.

Patients with known hypersensitivity to oxygen or those for whom supplemental oxygen is contraindicated, such as individuals with certain types of chronic obstructive pulmonary disease who are at risk of CO₂ retention, should not receive this therapy without careful medical evaluation.